MedTrace Logo

Effect of a Specific Phenolic Compound on Blood Pressure

NCT02628353 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2017-02-01

No results posted yet for this study

Summary

The study's main objective is to investigate the effects of acute consumption of a preparation containing 100 mg of a specific phenolic compound (patent pending, P201531587) on systolic BP after ingestion of a high fat meal.

Conditions

  • Cardiovascular Risk Factors
  • Blood Pressure

Interventions

DIETARY_SUPPLEMENT

placebo

1 capsule of placebo product (100 mg carboxymetylcellulose) in one visit

DIETARY_SUPPLEMENT

phenolic compound

1 capsule of phenolic compound product (100mg phenolic compound + 100 mg carboxymetylcellulose) in one visit

Sponsors & Collaborators

  • University Rovira i Virgili

    collaborator OTHER

  • Hospital Universitari Sant Joan de Reus

    collaborator OTHER

  • Fundació Catalana per a la Recerca i la Innovació (FCRI)

    collaborator UNKNOWN

  • Technological Centre of Nutrition and Health, Spain

    lead OTHER

Principal Investigators

  • Rosa Solà, PhD · University Rovira i Virgili / Hospital Universitari Sant Joan de Reus

  • Begoña Muguerza, PhD · University Rovira i Virgili

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-02-28
Completion
2017-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02628353 on ClinicalTrials.gov